Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy
- 21 March 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 21 (8), 2255-2265
- https://doi.org/10.1007/s00520-013-1782-y
Abstract
Purpose Fifty percent of patients develop chronic gastrointestinal (GI) symptoms following pelvic radiotherapy that adversely affect quality of life. Fewer than 20 % are referred to a gastroenterologist. We aimed to determine if structured gastroenterological evaluation is of benefit to this patient group. Methods Sixty patients with GI symptoms at ≥6 months after radical pelvic radiotherapy were identified prospectively from oncology clinics in this service evaluation. Those requiring urgent investigation were excluded. Patients were assessed at baseline using patient-reported questionnaires: inflammatory bowel disease questionnaire (IBDQ), Vaizey incontinence questionnaire, and the Common Terminology Criteria for Adverse Events (CTCAE) pelvis questionnaire. Participants were referred for gastroenterological evaluation using an algorithmic approach. Further assessments were made at 3 and 6 months. Results Twenty men and 36 women with primary gynecological (31), urological (17), or lower GI (8) tumors were included (mean age, 58.5 years). Median time from radiotherapy to baseline assessment was 3.0 years. Multiple GI symptoms were reported (median, 8; range, 4–16) including frequency, urgency, loose stool, fecal incontinence, flatulence, bloating/distension, and rectal bleeding. Common diagnoses included radiation proctopathy, bile acid malabsorption, diverticulosis, and colonic polyps. Statistically significant improvements in all questionnaire scores between baseline and 6 months were found: IBDQ (p = 0.014), Vaizey (p < 0.0005), and CTCAE rectum-bowel subset (p = 0.001). Conclusions Gastroenterological evaluation identifies significant, potentially treatable diagnoses in patients who develop chronic GI symptoms following pelvic radiotherapy. Some findings are incidental and unrelated to previous cancer treatment. Radiation-induced GI symptoms have historically been considered “untreatable.” We report the first data to show that structured gastroenterological assessment has the potential to improve outcome by identifying diagnoses and facilitating focused treatment.Keywords
This publication has 30 references indexed in Scilit:
- Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancerGut, 2011
- “Pelvic radiation disease”: New understanding and new solutions for a new disease in the era of cancer survivorshipScandinavian Journal of Gastroenterology, 2010
- Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ AuditClinical Oncology, 2010
- Defining pelvic-radiation disease for the survivorship eraThe Lancet Oncology, 2010
- Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancerEuropean Journal Of Cancer, 2009
- The impact of radiotherapy late effects on quality of life in gynaecological cancer patientsBritish Journal of Cancer, 2009
- Measurement tools for gastrointestinal symptoms in radiation oncologyCurrent Opinion in Supportive & Palliative Care, 2009
- Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy AgencyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patientsGynecologic Oncology, 2005
- The Natural History and Management of Radiation Induced Injury of the Gastrointestinal TractAnnals of Surgery, 1969